Rethinking CAR-T manufacturing paradigms: terminology, operational considerations, and economic trade-offs.
Saved in:
| Title: | Rethinking CAR-T manufacturing paradigms: terminology, operational considerations, and economic trade-offs. |
|---|---|
| Authors: | McCann C; Children's National Medical Center, Washington, DC, USA., Matriccino J; Children's National Medical Center, Washington, DC, USA., Lowdell M; University College London, London, UK., Foster J; Ori Biotech, MAYDE, London, UK., Abraham E; Minaris Advanced Therapies, Philadelphia, Pennsylvania, USA., Hewitt M; Charles River Laboratories, Wilmington, Massachusetts, USA., Astigarraga RG; Galapagos, Generaal De Wittelaan L11 A3, Mechelen, Belgium., Lechich R; Global OT/IT Quality Services, Lambertville, New Jersey, USA., Lembong J; Alliance for Regenerative Medicine, Washington, DC, USA. Electronic address: jlembong@alliancerm.org. |
| Source: | Cytotherapy [Cytotherapy] 2026 Apr 12; Vol. 28 (8), pp. 102884. Date of Electronic Publication: 2026 Apr 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
